• English


Undergraduate Degree

  • Carleton College , 2004 , Northfield , MN

Graduate Degree

  • University of Wisconsin-Madison , 2008 , Madison , WI

Medical School

  • Medical College of Wisconsin , 2012 , Milwaukee , WI


  • Boston Combined Residency Program (BCRP) , 2015 , Boston , MA


  • Harvard Medical Toxicology Program , 2017 , Boston , MA


Pediatric Emergency Medicine Fellowship
  • Boston Children's Hospital , 2019 , Boston , MA


Dr. Michael Toce completed his undergraduate studies at Carleton College where he received a B.A. in biology and biochemistry. He received a M.S. in bacteriology from the University of Wisconsin-Madison, and his M.D. from the Medical College of Wisconsin. He completed his pediatrics residency at the Boston Combined Residency Program before completing a Medical Toxicology Fellowship and Pediatric Emergency Medicine Fellowship at Boston Children's Hospital. He is currently an attending in the Boston Children's Hospital Emergency Department and works as a Medical Toxicologist at the MA/RI Poison Control Center.


  • American Board of Pediatrics, General Pediatrics
  • American Board of Pediatrics, Medical Toxicology


Publications powered by Harvard Catalyst Profiles

  1. Trends in Benzodiazepine Prescribing for US Adolescents and Young Adults From 2008 to 2019. JAMA Pediatr. 2021 Dec 20. View abstract
  2. Pediatric cannabis use and cardiac complications. CMAJ. 2021 11 15; 193(45):E1737. View abstract
  3. COVID-19 and Pediatric Ingestions. Pediatrics. 2021 07; 148(1). View abstract
  4. Commentary on Hill et al.: Breaking down barriers-increasing access to lifesaving opioid use disorder medications to save lives. Addiction. 2021 06; 116(6):1512-1513. View abstract
  5. Clinical Effects of Pediatric Clonidine Exposure: A Retrospective Cohort Study at a Single Tertiary Care Center. J Emerg Med. 2021 Jan; 60(1):58-66. View abstract
  6. Association of State-Level Opioid-Reduction Policies With Pediatric Opioid Poisoning. JAMA Pediatr. 2020 10 01; 174(10):961-968. View abstract
  7. Neonate With Abdominal Distention. Ann Emerg Med. 2019 Apr; 73(4):e41-e42. View abstract
  8. Case 1: A Medically Complex 10-month-old Boy with Lethargy. Pediatr Rev. 2019 Feb; 40(2):79-81. View abstract
  9. Prolonged central apnoea after intravenous morphine administration in a 12-year-old male with a UGT1A1 loss-of-function polymorphism. Br J Clin Pharmacol. 2019 01; 85(1):258-262. View abstract
  10. Pharmacologic Treatment of Opioid Use Disorder: a Review of Pharmacotherapy, Adjuncts, and Toxicity. J Med Toxicol. 2018 12; 14(4):306-322. View abstract
  11. Myocardial Infarct After Marijuana Inhalation in a 16-year-old Adolescent Boy. Pediatr Dev Pathol. 2019 Jan-Feb; 22(1):80-86. View abstract
  12. Acute Amnestic Syndrome Associated with Fentanyl Overdose. N Engl J Med. 2018 Mar 22; 378(12):1157-1158. View abstract
  13. A case report of methadone-associated hypoglycemia in an 11-month-old male. Clin Toxicol (Phila). 2018 01; 56(1):74-76. View abstract
  14. The Poisoned Pediatric Patient. Pediatr Rev. 2017 May; 38(5):207-220. View abstract
  15. A Case Report of Reversible Takotsubo Cardiomyopathy after Amphetamine/Dextroamphetamine Ingestion in a 15-Year-Old Adolescent Girl. J Pediatr. 2017 03; 182:385-388.e3. View abstract
  16. Clinical effects of unintentional pediatric buprenorphine exposures: experience at a single tertiary care center. Clin Toxicol (Phila). 2017 Jan; 55(1):12-17. View abstract